Advertisement

Novel Therapeutics for Rare Lymphomas

  • Christopher Dittus
Book

Table of contents

  1. Front Matter
    Pages i-x
  2. Renee Betancourt, Yuri Fedoriw
    Pages 1-13
  3. Shayna Sarosiek, Jorge J. Castillo
    Pages 15-26
  4. Raghuveer Ranganathan, Thomas C. Shea
    Pages 27-46
  5. Daniel R. Reed, Craig A. Portell
    Pages 69-82
  6. Christin B. DeStefano, Kieron Dunleavy, Catherine Lai
    Pages 83-100
  7. Thomas A. Guerrero-Garcia, Jorge J. Castillo
    Pages 101-118
  8. Raghuveer Ranganathan, Natalie Sophia Grover
    Pages 119-135
  9. Luis Malpica Castillo, Christopher Dittus
    Pages 137-164
  10. Mary Beth Seegars, Zanetta S. Lamar
    Pages 165-178
  11. Austin Kim, Eric Jacobsen
    Pages 179-189
  12. Stephanie Teja, Neha Mehta-Shah
    Pages 191-208
  13. Shekeab Jauhari, Matt McKinney
    Pages 209-220
  14. Timothy J. Voorhees, Edith V. Bowers, Christopher R. Kelsey, Yara Park, Anne W. Beaven
    Pages 221-246
  15. Back Matter
    Pages 247-253

About this book

Introduction

This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

Keywords

lymphoma novel therapeutics for rare lymphomas rare lymphomas novel therapeutics t-cell lymphomas aggressive lymphomas b-cell lymphomas

Editors and affiliations

  • Christopher Dittus
    • 1
  1. 1.Department of Medicine, Division of Hematology and OncologyUniversity of North Carolina at Chapel HillChapel HillUSA

Bibliographic information

Industry Sectors
Pharma
Health & Hospitals
Biotechnology
Oncology & Hematology